WoS
🏆 JCR Q3 · JIF 2,5
YÖKSİS Eşleşti
2025 Article 4. Yazar
Infliximab ameliorates vancomycin-triggered nephrotoxicity: Biochemical, molecular, and histopathological insights
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
·
Cilt 782
·
ISSN 0006-291X
Doç. Dr. MEHMET BURAK ATEŞ
· 6 yazar
WoS
🏆 JCR Q1 · JIF 3,3 2024 Article 11. Yazar
Efficacy and Safety of CT-P13 as First- and Second-Line Treatment in Patients with Ankylosing Spondylitis
JOURNAL OF CLINICAL MEDICINE
·
Cilt 13
Prof. Dr. SEMA YILMAZ
· 28 yazar
WoS
YÖKSİS Eşleşti
2017 Article 5. Yazar
Infliximab alleviates the mortality, mesenteric hypoperfusion, aortic dysfunction, and multiple organ damage in septic rats
CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY
·
Cilt 95, s. 866-872
·
ISSN 0008-4212
WoS
🏆 JCR Q1 · JIF 3,8
YÖKSİS Eşleşti
2012 Article 7. Yazar
Protective Effect of Infliximab on Ischemia/Reperfusion-Induced Damage in Rat Kidney
RENAL FAILURE
·
Cilt 34, s. 1144-1149
·
ISSN 0886-022X